A systematic review of curricula on relationships between residents and the pharmaceutical industry

Medical Education

Volumn 42, Issue 3, 2008, Pages 301-308

  Montague, Brian T ^a,b   Fortin VI, Auguste H ^a   Rosenbaum, Julie ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WATERBURY HOSPITAL   (United States)

Author keywords

*drug industry; *internship and residency; *interprofessional relations; Curriculum; Review publication type

Indexed keywords

ARTICLE; CURRICULUM; DRUG INDUSTRY; DRUG MARKETING; FOLLOW UP; HUMAN; MEDICAL SPECIALIST; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; RESIDENCY EDUCATION; SYSTEMATIC REVIEW;

CURRICULUM; DRUG INDUSTRY; INTERNSHIP AND RESIDENCY; INTERPROFESSIONAL RELATIONS;

EID: 38949171351     PISSN: 03080110     EISSN: 13652923     Source Type: Journal    
DOI: 10.1111/j.1365-2923.2007.02998.x     Document Type: Article

References (22)

1. House of Commons Health Committee. The Influence of the Pharmaceutical Industry: Fourth Report of Session 2004-2005. 2005 1 126. http://www. publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/42.pdf Accessed 10 January 2008 S. Doctors and drug makers: a move to end cozy ties. New York Times. 12 February 2007. http://www.nytimes.com/2007/02/12/business/12drug.html Accessed 10 January 2008 M, Kerridge I. Doctors behaving badly. Med J Aust 2006 185 (6 299 300.
2. Wazana A, Granich A, Primeau F, Bhanji NH, Jalbert M. Using the literature in developing McGill's guidelines for interactions between residents and the pharmaceutical industry. Acad Med 2004 79 (11 1033 40.
3. Lexchin J. Interactions between physicians and the pharmaceutical industry. CMAJ 1993 149 (10 1401 7.
4. Wilkes MS, Hoffman JR. An innovative approach to educating medical students about pharmaceutical promotion. Acad Med 2001 76 (12 1271 7.
5. Steinman M, Shlipak M, McPhee S. Of principles and pens. Am J Med 2001 110 : 551 7.
6. Brennan TA, Rothman DJ, Blank L et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centres. JAMA 2006 295 (4 429 33.
7. Coleman D, Kazdin A, Miller L, Morrow J, Udelsman R. Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach. Acad Med 2006 81 (2 154 60.
8. McCormick B, Tomlinson G, Brill-Edwards P, Detsky A. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on post-training attitudes and behaviour. JAMA 2001 286 (16 1994 9.
9. Stanford University School of Medicine. Policy and Guidelines for Interactions between the Stanford University School of Medicine, the Stanford Hospital and Clinics, and Lucile Packard Children's Hospital with the Pharmaceutical, Biotech, Medical Device, and Hospital and Research Equipment and Supplies Industries ('Industry'). 10 January 2006, http://med.stanford.edu/coi/ siip/policy.html. [Accessed 2 December 2007.]
10. Hospital of the University of Pennsylvania. Guidelines for Interactions between Healthcare Professionals and Industry. http://www.uphs.upenn.edu/cep/ resources/PhARMA%202-202006%20prof-industry.pdf Accessed 10 January 2008 DA, Steinman MA. Interactions between pharmaceutical representatives and doctors in training. A thematic review. J Gen Intern Med 2005 20 (8 777 86.
11. Green M. Identifying, appraising, and implementing medical education curricula. Ann Intern Med 2001 135 : 889 96.
12. Bayliff CD, Edington RD, Johnston LJ, Shaw PW, Bailey DG. Impact of a pharmacist on the educational value of pharmaceutical industry film showings. Can J Hosp Pharm 1991 44 (6 283 7.
13. Agrawal S, Saluja I, Kaczorowski J. A prospective before-and-after trial of an educational intervention about pharmaceutical marketing. Acad Med 2004 79 (11 1046 50.
14. Anastasio GD, Little JM Jr. Pharmaceutical marketing: implications for medical residency training. Pharmacotherapy 1996 16 (1 103 7.
15. Hopper JA, Speece MW, Musial JL. Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives. J Gen Intern Med 1997 12 (10 639 42.
16. Kelcher S, Brownoff R, Meadows LM. Structured approach to pharmaceutical representatives. Family medicine residency programme. Can Fam Physician 1998 44 : 1053 6.
17. Watkins RS, Kimberly J Jr. What residents don't know about physician-pharmaceutical industry interactions. Acad Med 2004 79 (5 432 7.
18. Schneider JA, Arora V, Kasza K, Van Harrison R, Humphrey H. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention. Acad Med 2006 81 (7 595 602.
19. Randall ML, Rosenbaum JR, Rohrbaugh RM, Rosenheck RA. Attitudes and behaviours of psychiatry residents toward pharmaceutical representatives before and after an educational intervention. Acad Psychiatry 2005 29 (1 33 9.
20. Shear N, Black F, Lexchin J. Examining the physician-detailer interaction. Can J Clin Pharmacol 1996 3 (4 175 9.
21. Shaughnessy AF, Slawson DC, Bennett JH. Teaching information mastery: evaluating information provided by pharmaceutical representatives. Fam Med 1995 27 (9 581 5.
22. McKinney WP, Schiedermayer DL, Lurie N, Simpson DE, Goodman JL, Rich EC. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA 1990 264 : 1693 7.